Y-Intercept (HK)
ALT icon

Y-Intercept (HK)’s Altimmune ALT Stock Holding History

Y-Intercept (HK)’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$71.9K Buy
+25,136
New +$77.1K ﹤0.01% 1519
2023
Q2 		– Sell
-32,695
Closed -$138K – 1236
2023
Q1 		$138K Buy
+32,695
New +$388K 0.02% 1021

Other funds holding ALT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Beirne Wealth Consulting Services
Beirne Wealth Consulting Services Shelton, Connecticut $505M AUM 16.24% 1-Year Est. Return

Y-Intercept (HK)'s ALT Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Altimmune (ALT) in Q3 2026: 25,136 shares worth $71.9K. The stake represents ﹤0.01% of the portfolio and ranks #1519 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ALT as recently as Q1 2023.

Y-Intercept (HK) first reported a position in ALT in Q1 2023 and has held it in 2 quarters since. The position peaked at $138K in Q1 2023. 75 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Y-Intercept (HK) held 25,136 shares of Altimmune worth $71.9K as of Q3 2026.
  • Altimmune was a new Y-Intercept (HK) position in Q3 2026.
  • Altimmune made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1519 holding.
  • Y-Intercept (HK) first reported a position in Altimmune in Q1 2023 and has held it in 2 quarters since.
  • Y-Intercept (HK)'s Altimmune position peaked at $138K in Q1 2023.
  • 75 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.